OpenURL Connection Search

Select item for more details and to access through your institution.

Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.
Published in:
Journal of Signal Transduction, 2010, p. 1, doi. 10.1155/2010/584657
By:
- Ruvolo, Vivian R.;
- Karanjeet, Kul B.;
- Schuster, Todd F.;
- Brown, Rhoderick;
- Deng, Yibin;
- Hinchcliffe, Edward;
- Ruvolo, Peter P.
Publication type:
Article
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
Published in:
Cancers, 2024, v. 16, n. 8, p. 1448, doi. 10.3390/cancers16081448
By:
- van Dijk, Anneke D.;
- Hoff, Fieke W.;
- Qiu, Yihua;
- Hubner, Stefan E.;
- Go, Robin L.;
- Ruvolo, Vivian R.;
- Leonti, Amanda R.;
- Gerbing, Robert B.;
- Gamis, Alan S.;
- Aplenc, Richard;
- Kolb, Edward A.;
- Alonzo, Todd A.;
- Meshinchi, Soheil;
- de Bont, Eveline S. J. M.;
- Horton, Terzah M.;
- Kornblau, Steven M.
Publication type:
Article
Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells.
Published in:
Journal of Cellular Biochemistry, 2011, v. 112, n. 6, p. 1696, doi. 10.1002/jcb.23090
By:
- Ruvolo, Peter P.;
- Zhou, Liran;
- Watt, Julie C.;
- Ruvolo, Vivian R.;
- Burks, Jared K.;
- Jiffar, Tilahun;
- Kornblau, Steven;
- Konopleva, Marina;
- Andreeff, Michael
Publication type:
Article
MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S2, doi. 10.1016/j.clml.2017.09.025
By:
- Qi Zhang;
- Han, Lina;
- Rongqing Pan;
- Ce Shi;
- Jeremy, Ryan;
- Man Chun John Ma;
- Kurtz, Steven;
- Hong Mu;
- Ruvolo, Vivian R.;
- Ma, Helen;
- Yingchang Mi;
- Tyner, Jeffrey;
- Anthony, Letai;
- Davis, Richard Eric;
- Andreeff, Michael;
- Konopleva, Marina
Publication type:
Article
Targeting MAPK Signaling Pathway with Cobimetinib (GDC-0973) Enhances Anti-Leukemia Efficacy of Venetoclax (ABT-199/GDC-0199) in Acute Myeloid Leukemia Models.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S282, doi. 10.1016/j.clml.2017.07.064
By:
- Han, Lina;
- Zhang, Qi;
- Shi, Ce;
- Cavazos, Antonio;
- Ruvolo, Vivian R.;
- Leverson, Joel D.;
- Dail, Monique;
- Phillips, Darren C.;
- Chen, Jun;
- Jin, Sha S.;
- Jacamo, Rodrigo;
- Daver, Naval;
- Jabbour, Elias;
- Kantarjian, Hagop M.;
- Andreeff, Michael;
- Sampath, Deepak;
- Konopleva, Marina
Publication type:
Article
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.
Published in:
British Journal of Haematology, 2011, v. 155, n. 1, p. 125, doi. 10.1111/j.1365-2141.2011.08646.x
By:
- Rakheja, Dinesh;
- Konoplev, Sergej;
- Su, Mu;
- Wheeler, David;
- Muzny, Donna M.;
- Ruvolo, Vivian R.;
- Collins, Robert;
- Karandikar, Nitin J.;
- Andreeff, Michael;
- Medeiros, Leonard Jeffrey;
- Chen, Weina
Publication type:
Article
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Published in:
2022
By:
- Zhang, Qi;
- Riley-Gillis, Bridget;
- Han, Lina;
- Jia, Yannan;
- Lodi, Alessia;
- Zhang, Haijiao;
- Ganesan, Saravanan;
- Pan, Rongqing;
- Konoplev, Sergej N.;
- Sweeney, Shannon R.;
- Ryan, Jeremy A.;
- Jitkova, Yulia;
- Dunner Jr, Kenneth;
- Grosskurth, Shaun E.;
- Vijay, Priyanka;
- Ghosh, Sujana;
- Lu, Charles;
- Ma, Wencai;
- Kurtz, Stephen;
- Ruvolo, Vivian R.
Publication type:
Correction Notice
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Published in:
Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-021-00870-3
By:
- Zhang, Qi;
- Riley-Gillis, Bridget;
- Han, Lina;
- Jia, Yannan;
- Lodi, Alessia;
- Zhang, Haijiao;
- Ganesan, Saravanan;
- Pan, Rongqing;
- Konoplev, Sergej N.;
- Sweeney, Shannon R.;
- Ryan, Jeremy A.;
- Jitkova, Yulia;
- Dunner Jr, Kenneth;
- Grosskurth, Shaun E.;
- Vijay, Priyanka;
- Ghosh, Sujana;
- Lu, Charles;
- Ma, Wencai;
- Kurtz, Stephen;
- Ruvolo, Vivian R.
Publication type:
Article
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Published in:
Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-021-00870-3
By:
- Zhang, Qi;
- Riley-Gillis, Bridget;
- Han, Lina;
- Jia, Yannan;
- Lodi, Alessia;
- Zhang, Haijiao;
- Ganesan, Saravanan;
- Pan, Rongqing;
- Konoplev, Sergej N.;
- Sweeney, Shannon R.;
- Ryan, Jeremy A.;
- Jitkova, Yulia;
- Dunner Jr, Kenneth;
- Grosskurth, Shaun E.;
- Vijay, Priyanka;
- Ghosh, Sujana;
- Lu, Charles;
- Ma, Wencai;
- Kurtz, Stephen;
- Ruvolo, Vivian R.
Publication type:
Article
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Published in:
Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-021-00870-3
By:
- Zhang, Qi;
- Riley-Gillis, Bridget;
- Han, Lina;
- Jia, Yanan;
- Lodi, Alessia;
- Zhang, Haijiao;
- Ganesan, Saravanan;
- Pan, Rongqing;
- Konoplev, Sergej N.;
- Sweeney, Shannon R.;
- Ryan, Jeremy A.;
- Jitkova, Yulia;
- Dunner Jr, Kenneth;
- Grosskurth, Shaun E.;
- Vijay, Priyanka;
- Ghosh, Sujana;
- Lu, Charles;
- Ma, Wencai;
- Kurtz, Stephen;
- Ruvolo, Vivian R.
Publication type:
Article

Found: 10